Exact Mass: 335.0915

Exact Mass Matches: 335.0915

Found 56 metabolites which its exact mass value is equals to given mass value 335.0915, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-(Phosphonomethyl)-5-phenyl-D-phenylalanine

(+)-alpha-Amino-3-(5-phosphonomethyl-[1.1-biphenyl]-3-yl) propanoic acid

C16H18NO5P (335.0923)

Pirifibrate

(6-(Hydroxymethyl)-2-pyridyl)methyl-2-(4-chlorophenoxy)-2-methyl-propionate hydrochloride

C17H18ClNO4 (335.0924)

Sulotroban

2-[4-(2-Benzenesulphonamidoethyl)phenoxy]acetic acid

C16H17NO5S (335.0827)

RD 01A7

C16H17NO7 (335.1005)

Fenamiphos sulfone

C13H22NO5PS (335.0956)

CONFIDENCE standard compound; EAWAG_UCHEM_ID 3703

2-C-(4-methoxyindol-3-ylmethyl)-beta-L-xylo-3-hexulofuranosonic acid gamma-lactone|4-methoxyascorbigen

C16H17NO7 (335.1005)

O1-(6-amino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Amino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C16H17NO7 (335.1005)

11-Oxotetrodotoxin

C11H17N3O9 (335.0965)

Asp Asp Ser

C11H17N3O9 (335.0965)

Ser Asp Asp

C11H17N3O9 (335.0965)

Asp Ser Asp

C11H17N3O9 (335.0965)

n-methyl-4-(p-formylstyryl)pyridinium methylsulfate

C16H17NO5S (335.0827)

[(3R)-1-(3-fluorophenyl)pyrrolidin-3-yl] 4-methylbenzenesulfonate

C17H18FNO3S (335.0991)

Sulotroban

C16H17NO5S (335.0827)

C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents

Adenosine,2-(trifluoromethyl)- (7CI,8CI,9CI)

C11H12F3N5O4 (335.0841)

Amlodipine besilate impurity G

C17H18ClNO4 (335.0924)

BIS-(4-NITROPHENYL)PHENYLAMINE

C18H13N3O4 (335.0906)

4-Chloro-7-fluoro-6-[2-(4-morpholinyl)ethoxy]-3-quinolinecarbonit rile

C16H15ClFN3O2 (335.0837)

Clanfenur

C16H15ClFN3O2 (335.0837)

(4-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

C15H18BNO5S (335.0999)

N-[4-(TRIFLUOROMETHYL)BENZOYL]-L-METHIONINYL HYDRAZIDE

C13H16F3N3O2S (335.0915)

2,12-DIFORMYL-DIBENZO[C,H]ACRIDINE

C23H13NO2 (335.0946)

Pirifibrate

C17H18ClNO4 (335.0924)

C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

4-(benzothiazol-2-ylazo)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one

C17H13N5OS (335.0841)

Febuxostat dicarboxylic acid impurity

C16H17NO5S (335.0827)

4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester

C16H17NO7 (335.1005)

(2-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

C15H18BNO5S (335.0999)

Ischemin

C15H17N3O4S (335.094)

Asp-Ser-Asp

C11H17N3O9 (335.0965)

N-benzyl-3-(5-chloro-1,3-benzoxazol-2-yl)pyridin-2-amine

C19H14ClN3O (335.0825)

5-[1-[(4-Fluorophenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

C19H14FN3S (335.0892)

N-[1-methyl-3-(trifluoromethyl)-5-thieno[2,3-c]pyrazolyl]carbamic acid 2,2-dimethylpropyl ester

C13H16F3N3O2S (335.0915)

N-(5,5-dimethyl-7-oxo-4,6-dihydro-1,3-benzothiazol-2-yl)-2-(2,5-dioxo-1-pyrrolidinyl)acetamide

C15H17N3O4S (335.094)

3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine

C18H14ClN5 (335.0938)

({[(3E)-2-Oxo-2,7-dihydro-2,3-biindol-3(7H)-ylidene]amino}oxy)acetic acid

C18H13N3O4 (335.0906)

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

C12H17NO10-2 (335.0852)

4-[[Dimethoxyphosphoryl(phenyl)methyl]amino]benzoic acid

C16H18NO5P (335.0923)

2-(2,4-dioxo-3-thiazolidinyl)-N-[4-(4-morpholinyl)phenyl]acetamide

C15H17N3O4S (335.094)

4,5-Dimethoxy-2-[(1-oxo-2-thiophen-2-ylethyl)amino]benzoic acid methyl ester

C16H17NO5S (335.0827)

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

C18H13N3O4 (335.0906)

5,7-dimethyl-3-[3-(trifluoromethyl)phenyl]azo-1H-pyrazolo[1,5-a]pyrimidin-2-one

C15H12F3N5O (335.0994)

Asp-Asp-Ser

C11H17N3O9 (335.0965)

Ser-Asp-Asp

C11H17N3O9 (335.0965)

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

C12H17NO10 (335.0852)

A carbohydrate acid derivative anion obtained by deprotonation of both carboxy groups of (S)-malyl N-acetyl-alpha-D-glucosaminide; major species at pH 7.3.

(2r)-2-[(2s)-6-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H17NO7 (335.1005)

1-[2-methoxy-2-(4-nitrophenyl)ethanesulfonyl]-4-methylbenzene

C16H17NO5S (335.0827)

1-chloro-n-(2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl)methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)

(3s,3as,6s,6ar)-3,3a,6-trihydroxy-3-[(1-methoxyindol-3-yl)methyl]-dihydro-5h-furo[3,2-b]furan-2-one

C16H17NO7 (335.1005)

1-chloro-n-[(6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)

(2r)-17-oxa-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16(21),18-hexaene-7,15,20-trione

C18H13N3O4 (335.0906)

2-[6-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H17NO7 (335.1005)

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]propanoic acid

C16H17NO7 (335.1005)

1-chloro-n-[(2s,6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)